Enovis Corp. (ENOV)
27.82
+0.15
(+0.54%)
USD |
NYSE |
Dec 11, 16:00
27.16
-0.66
(-2.37%)
Pre-Market: 07:10
Enovis Cash from Investing (Quarterly): -56.06M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Baxter International, Inc. | -111.00M |
| Integra LifeSciences Holdings Corp. | -15.59M |
| Merit Medical Systems, Inc. | -24.06M |
| Repligen Corp. | -7.783M |
| Perspective Therapeutics, Inc. | 13.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 82.58M |
| Cash from Financing (Quarterly) | -36.91M |
| Free Cash Flow | 22.76M |
| Free Cash Flow Per Share (Quarterly) | 0.5088 |
| Free Cash Flow to Equity (Quarterly) | 52.60M |
| Free Cash Flow to Firm (Quarterly) | 50.06M |
| Free Cash Flow Yield | 1.44% |